SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2′-Deoxyguanosine
- 1 March 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (5), 929-936
- https://doi.org/10.1158/0008-5472.can-19-2257
Abstract
Cell membrane transporters facilitate the passage of nucleobases and nucleosides for nucleotide synthesis and metabolism, and are important for the delivery of nucleoside analogues used in anticancer drug therapy. Here, we investigated if cell membrane transporters are involved in the cellular uptake of the nucleoside analogue DNA damage mediator 6-thio-2′-deoxyguanosine (6-thio-dG). A large panel of non–small cell lung cancer (NSCLC) cell lines (73 of 77) were sensitive to 6-thio-dG; only four NSCLC lines were resistant to 6-thio-dG. When analyzed by microarray and RNA sequencing, the resistant NSCLC cell lines clustered together, providing a molecular signature for patients that may not respond to 6-thio-dG. Significant downregulation of solute carrier family 43 A3 (SLC43A3), an equilibrative nucleobase transporter, was identified as a candidate in this molecular resistance signature. High levels of SLC43A3 mRNA predicted sensitivity to 6-thio-dG and therefore SLC43A3 could serve as a promising biomarker for 6-thio-dG sensitivity in patients with NSCLC. Significance: These findings identify a biomarker of resistance to the telomeric DNA damage mediator 6-thio-2′-deoxyguanosine.Other Versions
Funding Information
- HHS | NIH | National Cancer Institute (P50CA70907)
- HHS | NIH | National Cancer Institute (5P30CA142543)
- HHS | NIH | National Cancer Institute (CA124334)
This publication has 19 references indexed in Scilit:
- The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffoldAntiviral Research, 2018
- Molecular Basis of Nucleobase Transport Systems in MammalsBiological & Pharmaceutical Bulletin, 2017
- Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine KinaseThe Journal of pharmacology and experimental therapeutics, 2016
- Functional identification of SLC43A3 as an equilibrative nucleobase transporter involved in purine salvage in mammalsScientific Reports, 2015
- A novel telomerase substrate precursor rapidly induces telomere dysfunction in telomerase positive cancer cells but not telomerase silent normal cellsOncoscience, 2015
- Regulation of mammalian nucleotide metabolism and biosynthesisNucleic Acids Research, 2015
- Induction of Telomere Dysfunction Mediated by the Telomerase Substrate Precursor 6-Thio-2′-DeoxyguanosineCancer Discovery, 2015
- The small SLC43 family: Facilitator system l amino acid transporters and the orphan EEG1Molecular Aspects of Medicine, 2013
- Physiology and Pathophysiology of Purinergic NeurotransmissionPhysiological Reviews, 2007
- The Biological Significance of Purine SalvageAnnual Review of Biochemistry, 1971